![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BRINP1 |
Gene summary for BRINP1 |
![]() |
Gene information | Species | Human | Gene symbol | BRINP1 | Gene ID | 1620 |
Gene name | BMP/retinoic acid inducible neural specific 1 | |
Gene Alias | DBC1 | |
Cytomap | 9q33.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | O60477 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1620 | BRINP1 | RNA-P3T-P3T-1 | Human | Lung | IAC | 1.19e-15 | 1.00e+00 | 0.1829 |
1620 | BRINP1 | RNA-P3T-P3T-2 | Human | Lung | IAC | 4.53e-15 | 9.84e-01 | 0.1835 |
1620 | BRINP1 | RNA-P3T-P3T-3 | Human | Lung | IAC | 4.38e-04 | 9.59e-01 | 0.1745 |
1620 | BRINP1 | RNA-P3T-P3T-4 | Human | Lung | IAC | 4.27e-23 | 1.21e+00 | 0.1859 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00073464 | Lung | IAC | regulation of mitotic cell cycle | 78/2061 | 457/18723 | 5.37e-05 | 1.21e-03 | 78 |
GO:00457861 | Lung | IAC | negative regulation of cell cycle | 67/2061 | 385/18723 | 9.74e-05 | 1.93e-03 | 67 |
GO:00459301 | Lung | IAC | negative regulation of mitotic cell cycle | 45/2061 | 235/18723 | 1.49e-04 | 2.73e-03 | 45 |
GO:00507675 | Lung | IAC | regulation of neurogenesis | 57/2061 | 364/18723 | 3.92e-03 | 3.24e-02 | 57 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BRINP1 | SNV | Missense_Mutation | c.2101G>T | p.Asp701Tyr | p.D701Y | O60477 | protein_coding | tolerated(0.12) | possibly_damaging(0.67) | TCGA-55-6972-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
BRINP1 | SNV | Missense_Mutation | c.811G>C | p.Glu271Gln | p.E271Q | O60477 | protein_coding | tolerated(0.31) | benign(0.174) | TCGA-55-8511-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
BRINP1 | SNV | Missense_Mutation | c.734C>T | p.Ser245Leu | p.S245L | O60477 | protein_coding | deleterious(0) | possibly_damaging(0.885) | TCGA-64-1679-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
BRINP1 | SNV | Missense_Mutation | c.732N>T | p.Gln244His | p.Q244H | O60477 | protein_coding | deleterious(0.02) | probably_damaging(0.948) | TCGA-64-5775-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | carboplatin | PD | |
BRINP1 | SNV | Missense_Mutation | novel | c.1953G>C | p.Lys651Asn | p.K651N | O60477 | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-69-7974-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
BRINP1 | SNV | Missense_Mutation | c.524G>T | p.Arg175Leu | p.R175L | O60477 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-73-A9RS-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | PD | |
BRINP1 | SNV | Missense_Mutation | novel | c.1158N>T | p.Gln386His | p.Q386H | O60477 | protein_coding | deleterious(0.03) | benign(0.018) | TCGA-78-7155-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | PD |
BRINP1 | SNV | Missense_Mutation | c.251N>G | p.Ala84Gly | p.A84G | O60477 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-86-A4D0-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | etoposide | CR | |
BRINP1 | SNV | Missense_Mutation | novel | c.502N>T | p.Ala168Ser | p.A168S | O60477 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-MN-A4N1-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
BRINP1 | SNV | Missense_Mutation | c.1448T>G | p.Phe483Cys | p.F483C | O60477 | protein_coding | deleterious(0) | possibly_damaging(0.849) | TCGA-MP-A4TD-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | cisplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |